注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
VistaGen Therapeutics Inc是一家臨床階段的生物製藥公司。該公司致力於為患有涉及中樞神經系統(CNS)的疾病和障礙的患者開發和商業化候選產品。其產品線包括PH94B,一種有潛力治療多種焦慮症的神經活性鼻噴霧劑,正準備進行社交焦慮症(SAD)的III期臨床試驗,自殺意念、神經性疼痛、左旋多巴誘發的運動障礙(LID)和癲癇。其AV-101是7-氯-氰尿酸(7-Cl-KYNA)的口服前藥,它是N-甲基-D-天冬氨酸受體(NMDAR)的甘氨酸共激動劑位點的有效和選擇性完全拮抗劑,抑制NMDAR的功能,NMDAR是大腦中的一種離子型谷氨酸受體。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Shawn K. Singh | 58 | 2000 | CEO & Director |
Gordon Keller | - | 2022 | Chairman of Scientific Advisory Board |
Sanjay Johan Mathew | - | 2016 | Member of Clinical & Regulatory Advisory Board |
Jerry B. Gin | 80 | 2016 | Independent Director |
Thomas P. Laughren | - | 2016 | Member of Clinical & Regulatory Advisory Board |
Mark A. Smith | 68 | 2016 | Member of the Advisory Board |
Michael B. Liebowitz | - | 2018 | Member of CNS Clinical and Regulatory Advisory Board |
Joanne Curley | 54 | 2021 | Independent Director |
Mary L. Rotunno | 63 | 2021 | Independent Director |
Margaret M. FitzPatrick | 57 | 2021 | Independent Chair of the Board |
Gerard Sanacora | - | 2015 | Member of Clinical & Regulatory Advisory Board |
Maurizio Fava | - | 2015 | Member of Clinical & Regulatory Advisory Board |
Mark Steven Wallace | - | 2017 | Member of Clinical & Regulatory Advisory Board |
Ann Michelle Cunningham | 55 | 2019 | Director |
Jon S. Saxe | 88 | 2000 | Independent Lead Director and Life Science Advisor |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核